Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × Palliative Care × 90 days × Clear all

Sponsor

Conditions

Neoplasms 5 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Lung Neoplasms 2 Leukemia 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Stress Disorders, Post-Traumatic 1 Squamous Cell Carcinoma of Head and Neck 1 Signs and Symptoms 1 Sarcoma 1 Penile Neoplasms 1 Ovarian Neoplasms 1 Motor Activity 1 Melanoma 1 Malignant Solid Neoplasm 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Inflammatory Breast Neoplasms 1 Gastrointestinal Neoplasms 1 Fatigue 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Cognition Disorders 1 Chemotherapy-Related Cognitive Impairment 1 Chemotherapy Effect 1

Interventions

capivasertib 2 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 copanlisib 1 axicabtagene ciloleucel 1 Receptors, Interleukin-6 1 Interleukin 1 Receptor Antagonist Protein 1 Fulvestrant 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡